Literature DB >> 27761276

Advantages of Pressurized-Spray Cryosurgery in Giant Cell Tumors of the Bone.

Nevzat Dabak1, Hasan Göçer1, Alper Çıraklı2.   

Abstract

BACKGROUND: Giant Cell Tumor is considered a benign, local and aggressive tumor. Although considered a benign bone tumor, it is still the subject of discussion and research because of the associated local bone destruction, as well as high rates of recurrence and distant metastases. Options are being developed for both surgical techniques and adjuvant therapies. AIMS: The present study evaluated the administration of cryotherapy via a pressurized-spray technique in giant cell tumors of the bone. STUDY
DESIGN: Cross-sectional study.
METHODS: The study included 40 patients who were treated with extensive curettage and cryotherapy at various locations during the period from February 2006 to December 2013. Informed consent forms were obtained from the participants and ethics committee approval was taken from the local ethics committee of Ondokuz Mayıs University. The pressurized-spray technique was performed using liquid nitrogen. The patients were evaluated with respect to age, gender, radiological appearance, treatment modality, duration of follow-up, skin problems and recurrence.
RESULTS: Twenty-one patients were female; 19 were male. The average age of the patients was 33 years (range: 16-72 years), and the average duration of follow-up was 43 months (range: 12-80 months). The average time from the onset of the complaints to the diagnosis was 6 months (range: 2-12 months). Based on the Campanacci classification: 9 patients were Grade I; 25 patients were Grade II; six patients were Grade III. The lesion was located in the femur in 14 patients, in the tibia in 11 patients, in the radius in 5 patients, in the pelvis in 4 patients, in the fibula in 3 patients, in the metatarsal in 2 patients and in the phalanges of the hand in one patient. One patient had postoperative early fracture. None of the patients had skin problems and infection. Three (7.5%) of the patients had recurrence.
CONCLUSION: It was found that cryotherapy was highly effective in the lesions, especially those located in the femur and tibia and remained insufficient in the lesions expanded outside the cortex. Wound healing problems, infection and fracture risk are lower with this technique.

Entities:  

Keywords:  Giant cell tumor; bone; cryotherapy; pressurized-spray technique; surgical treatment

Year:  2016        PMID: 27761276      PMCID: PMC5056651          DOI: 10.5152/balkanmedj.2016.150473

Source DB:  PubMed          Journal:  Balkan Med J        ISSN: 2146-3123            Impact factor:   2.021


  31 in total

1.  Early results of a modified technique of cryosurgery.

Authors:  Nevzat Dabak; Yilmaz Tomak; Ahmet Piskin; Birol Gulman; Hakan Ozcan
Journal:  Int Orthop       Date:  2003-05-20       Impact factor: 3.075

2.  Which treatment is the best for giant cell tumors of the distal radius? A meta-analysis.

Authors:  Yu-Peng Liu; Kang-Hua Li; Bu-Hua Sun
Journal:  Clin Orthop Relat Res       Date:  2012-07-07       Impact factor: 4.176

3.  Fracture risk with pressurized-spray cryosurgery.

Authors:  R Jay Lee; Joel L Mayerson; Martha Crist
Journal:  Am J Orthop (Belle Mead NJ)       Date:  2011-06

4.  Freezing bone without excision. An experimental study of bone-cell destruction and manner of regrowth in dogs.

Authors:  A A Gage; G W Greene; M E Neiders; F G Emmings
Journal:  JAMA       Date:  1966-05-30       Impact factor: 56.272

5.  Radiotherapy in the management of giant cell tumor of bone.

Authors:  Wenyin Shi; Daniel J Indelicato; John Reith; Kristy B Smith; Christopher G Morris; Mark T Scarborough; Charles P Gibbs; William M Mendenhall; Robert A Zlotecki
Journal:  Am J Clin Oncol       Date:  2013-10       Impact factor: 2.339

6.  Cement is recommended in intralesional surgery of giant cell tumors: a Scandinavian Sarcoma Group study of 294 patients followed for a median time of 5 years.

Authors:  Aarne H Kivioja; Carl Blomqvist; Kalevi Hietaniemi; Clement Trovik; Anders Walloe; Henrik C F Bauer; Peter H Jorgensen; Peter Bergh; Gunnar Follerås
Journal:  Acta Orthop       Date:  2008-02       Impact factor: 3.717

7.  Giant-cell tumor of the appendicular skeleton.

Authors:  Michelle A Ghert; Marco Rizzo; John M Harrelson; Sean P Scully
Journal:  Clin Orthop Relat Res       Date:  2002-07       Impact factor: 4.176

8.  Giant-cell tumor of bone.

Authors:  M Campanacci; N Baldini; S Boriani; A Sudanese
Journal:  J Bone Joint Surg Am       Date:  1987-01       Impact factor: 5.284

Review 9.  Cryosurgery and acrylic cementation as surgical adjuncts in the treatment of aggressive (benign) bone tumors. Analysis of 25 patients below the age of 21.

Authors:  M M Malawer; W Dunham
Journal:  Clin Orthop Relat Res       Date:  1991-01       Impact factor: 4.176

10.  Giant cell tumor of bone: treatment and outcome of 214 cases.

Authors:  Maurice Balke; Laura Schremper; Carsten Gebert; Helmut Ahrens; Arne Streitbuerger; Gabriele Koehler; Jendrik Hardes; Georg Gosheger
Journal:  J Cancer Res Clin Oncol       Date:  2008-03-06       Impact factor: 4.553

View more
  4 in total

1.  Reconstruction of hand in aggressive benign bone tumors by mini JESS fixator.

Authors:  Abhishek Vaish; Jainish Patel; Raju Vaishya
Journal:  J Clin Orthop Trauma       Date:  2020-05-16

2.  Comparative Analysis of Two Surgical Treatment Options for Giant Cell Tumor of the Proximal Femur: Extended Curettage and Segmental Resection.

Authors:  Yuhao Yuan; Qing Liu; Yupeng Liu; Ziyi Wu; Wei Zhong; Hongbo He; Wei Luo
Journal:  Front Oncol       Date:  2021-12-20       Impact factor: 6.244

Review 3.  Global Prevalence and Risk of Local Recurrence Following Cryosurgery of Giant Cell Tumour of Bone: A Meta-Analysis.

Authors:  Shyful Nizam Sumari; Nor Azman Mat Zin; Wan Faisham Wan Ismail; Md Asiful Islam
Journal:  Cancers (Basel)       Date:  2022-07-08       Impact factor: 6.575

4.  Expression of MMP-2 and TIMP-3 with incidence and prognosis of giant-cell tumor of the bone.

Authors:  Zhendong Liu; Yuxin Ren; Fuqiang Zhu
Journal:  Oncol Lett       Date:  2018-05-10       Impact factor: 2.967

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.